Get startedLog in
    Picture of Kdventures AB logo

    KDV B — Kdventures AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    FinancialsSpeculativeMicro CapSucker Stock
    All News

    Brief: Karolinska Development's Modus Therapeutics Gets Approval For 2nd Part Of Phase 2 Study

    Picture of Kdventures AB logoKdventures AB
    04/11/2025 07:50
    Nov 4 (Reuters) - Karolinska Development AB KDEV.ST:

REG-KAROLINSKA DEVELOPMENT'S PORTFOLIO COMPANY MODUS THERAPEUTICS RECEIVES APPROVAL FOR SECOND PART OF PHASE 2 STUDY IN CHRONIC KIDNEY DISEASE WITH ANEMIA

Source text: ID:nGNE6VcJYY

Further company coverage: KDEV.ST

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Kdventures AB

    See all news